BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,061,695 | -7.2% | 81,126 | +12.0% | 0.01% | -7.7% |
Q2 2023 | $3,299,302 | +16.6% | 72,417 | +3.8% | 0.01% | +8.3% |
Q1 2023 | $2,828,862 | +108.2% | 69,745 | +161.7% | 0.01% | +100.0% |
Q4 2022 | $1,358,514 | +11.9% | 26,653 | +18.2% | 0.01% | 0.0% |
Q3 2022 | $1,214,000 | +5.8% | 22,541 | +26.3% | 0.01% | +20.0% |
Q2 2022 | $1,147,000 | +22.9% | 17,853 | +48.4% | 0.01% | +25.0% |
Q1 2022 | $933,000 | +60.3% | 12,034 | +77.5% | 0.00% | +100.0% |
Q4 2021 | $582,000 | +63.5% | 6,779 | +53.0% | 0.00% | 0.0% |
Q3 2021 | $356,000 | -36.0% | 4,431 | -35.9% | 0.00% | -33.3% |
Q2 2021 | $556,000 | -12.4% | 6,910 | -8.2% | 0.00% | 0.0% |
Q1 2021 | $635,000 | -85.7% | 7,528 | -86.4% | 0.00% | -88.0% |
Q4 2020 | $4,444,000 | +3.1% | 55,384 | +3.4% | 0.02% | -10.7% |
Q3 2020 | $4,309,000 | -6.3% | 53,576 | -0.0% | 0.03% | -15.2% |
Q2 2020 | $4,601,000 | +20.7% | 53,596 | +14.2% | 0.03% | +3.1% |
Q1 2020 | $3,811,000 | -17.1% | 46,943 | -14.6% | 0.03% | -8.6% |
Q4 2019 | $4,599,000 | +895.5% | 54,997 | +940.6% | 0.04% | +775.0% |
Q3 2019 | $462,000 | +17.3% | 5,285 | +9.9% | 0.00% | +33.3% |
Q2 2019 | $394,000 | +2.6% | 4,811 | +1.9% | 0.00% | 0.0% |
Q1 2019 | $384,000 | +5.2% | 4,723 | -14.8% | 0.00% | -25.0% |
Q4 2018 | $365,000 | -15.5% | 5,542 | -1.0% | 0.00% | 0.0% |
Q3 2018 | $432,000 | +7.2% | 5,599 | +2.6% | 0.00% | 0.0% |
Q2 2018 | $403,000 | +3.3% | 5,457 | -9.0% | 0.00% | 0.0% |
Q1 2018 | $390,000 | -11.6% | 5,996 | -12.1% | 0.00% | -20.0% |
Q4 2017 | $441,000 | +7.6% | 6,819 | +4.3% | 0.01% | 0.0% |
Q3 2017 | $410,000 | +8.8% | 6,535 | +4.9% | 0.01% | 0.0% |
Q2 2017 | $377,000 | +1695.2% | 6,229 | +1419.3% | 0.01% | – |
Q1 2017 | $21,000 | +23.5% | 410 | +8.8% | 0.00% | – |
Q4 2016 | $17,000 | -19.0% | 377 | -15.5% | 0.00% | – |
Q3 2016 | $21,000 | +5.0% | 446 | 0.0% | 0.00% | – |
Q2 2016 | $20,000 | +5.3% | 446 | -2.4% | 0.00% | – |
Q1 2016 | $19,000 | -93.0% | 457 | -93.6% | 0.00% | -100.0% |
Q4 2015 | $271,000 | +10.2% | 7,103 | -5.4% | 0.01% | +66.7% |
Q3 2015 | $246,000 | -92.7% | 7,512 | -84.4% | 0.00% | -95.7% |
Q2 2015 | $3,369,000 | +5.4% | 48,178 | +3.2% | 0.07% | +2.9% |
Q1 2015 | $3,197,000 | -3.6% | 46,669 | +3.2% | 0.07% | -5.6% |
Q4 2014 | $3,315,000 | -2.7% | 45,230 | -4.7% | 0.07% | -8.9% |
Q3 2014 | $3,407,000 | +70.2% | 47,474 | +71.5% | 0.08% | +83.7% |
Q2 2014 | $2,002,000 | -12.4% | 27,686 | -10.9% | 0.04% | -23.2% |
Q1 2014 | $2,285,000 | -0.4% | 31,059 | -5.8% | 0.06% | +3.7% |
Q4 2013 | $2,294,000 | -2.0% | 32,987 | -7.5% | 0.05% | -8.5% |
Q3 2013 | $2,342,000 | – | 35,649 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |